Adapted Physical Activity Education in Patients With Neurocognitive Disorder
EduAPA
1 other identifier
interventional
34
1 country
1
Brief Summary
This study aims to compare the effect of a program of Adapted Physical Activity (APA) versus the same program combined with a physical activity education program (PAE). Patients suffering from neurocognitive disorders (mild or early major) will be randomized into one of the two conditions. 3 complete evaluations will be done (inclusion M0, after 3 month of intervention M3, 3 months after the end of the intervention M6). The team except that APA+PEA will be more effectiv than the APA solely, on the following criteria : level of physical activity, cogntive function and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2023
CompletedFirst Posted
Study publicly available on registry
May 19, 2023
CompletedStudy Start
First participant enrolled
January 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 20, 2027
March 19, 2026
March 1, 2026
2.5 years
April 28, 2023
March 17, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
physical activity level
evolution of physical activity level will be assessed by actimetry on a 7 days period mesured by IPAQ score
at inclusion
physical activity level
evolution of physical activity level will be assessed by actimetry on a 7 days period mesured by IPAQ score
at 3 months after inclusion
physical activity level
evolution of physical activity level will be assessed by actimetry on a 7 days period mesured by IPAQ score
at 6 months after inclusion
Secondary Outcomes (30)
global cognition
at inclusion
global cognition
at 3 months after inclusion
global cognition
at 6 months after inclusion
executive functions
at inclusion
executive functions
at 3 months after inclusion
- +25 more secondary outcomes
Study Arms (2)
APA (adapted physical activity)
ACTIVE COMPARATOR24 APA sessions will take place, there will be 2 sessions a week for 12 weeks which will include global exercises for the upper and lower limb. One session will be 1 hour long and supervised by professionals. It will be divided in 4 cycles which will be differentiated by the intensity of its components: aerobic, strength, speed, balance, coordination and flexibility. The intensity of the sessions will be measured by RPE and heart rate monitor,
APA (adapted physical activity) + physical activity education (PAE)
EXPERIMENTAL24 APA sessions will take place, there will be 2 sessions a week for 12 weeks which will include global exercises for the upper and lower limb. One session will be 1 hour long and supervised by professionals. It will be divided in 4 cycles which will be differentiated by the intensity of its components: aerobic, strength, speed, balance, coordination and flexibility. The intensity of the sessions will be measured by RPE and heart rate monitor, \+ 8 individuals sessions of PAE (one per week, half an hour long) that will consist of advising and setting weekly goals related to improving PA level and sedentary behavior
Interventions
Eligibility Criteria
You may qualify if:
- mild neurocognitive disorder or early major neurocognitive disorder
You may not qualify if:
- Medical pathology involving the vital prognosis in the short term
- Major neurocognitive disorder at moderate stage and beyond (DSM 5) and/or MMSE \< 20
- Unbalanced depressive syndrom
- Contraindication to the practice of the exercises proposed during the study;
- Major hearing or visual impairment;
- Sufficiently active with regard to the daily recommendations described by the WHO
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nice University Hospital
Nice, 06000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2023
First Posted
May 19, 2023
Study Start
January 5, 2024
Primary Completion (Estimated)
June 20, 2026
Study Completion (Estimated)
August 20, 2027
Last Updated
March 19, 2026
Record last verified: 2026-03